Company profile
VASO Corp CIK 839087
Ticker
VASO (OTC)
Industry
Electromedical & Electrotherapeutic Apparatus
Headquarters
Plainview, NY 11803
Fiscal year end
2025 (FY)
Key Financials
Revenue
$89.10M
Net income
$1.57M
Total assets
$88.35M
Total liabilities
—
Stockholders' equity
$29.43M
Cash & equivalents
$35.05M
Operating income
-$2.89M
Operating cash flow
$9.27M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-3.2%
Net margin
1.8%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
33.3%
CapEx / revenue
—
Operating cash flow / net income
5.91×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$89.10M
$1.57M
$88.35M
—
$29.43M
2024
$86.77M
$951.0K
$82.94M
—
$27.70M
2023
$81.02M
$4.81M
$75.76M
—
$26.84M
2022
$79.29M
$11.29M
$71.65M
—
$22.07M
2021
$75.58M
$6.10M
$52.36M
—
$11.08M
Company Details
SIC code
3845
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-31
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Plainview, NY 11803
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:41 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.